NCT04192656View on ClinicalTrials.gov

The Effect of PAP on ISSHL Comorbided With OSA

PHASE4RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2029

Conditions
Sudden Hearing LossObstructive Sleep Apnea
Interventions
DEVICE

non-invasive positive airway pressure

non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea

DRUG

Methylprednisolone Hemisuccinate

Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss

DRUG

Ginaton

ginnaton is ginkgo biloba extract

Trial Locations (1)

100028

RECRUITING

Beijing Tsinhgua Changgung Hospital, Beijing

All Listed Sponsors
lead

Beijing Tsinghua Chang Gung Hospital

OTHER